Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abbott Labs | NYSE | Healthcare | Healthcare Equipment & Supplies | US$232.82B | 17.3x | 0.12 | US$133.73 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 7.1% Upside | Upgrade to Pro+ | |
Intuitive Surgical | NASDAQ | Healthcare | Healthcare Equipment & Supplies | US$188.95B | 75.8x | 3.43 | US$526.49 | -5.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 4.1% Upside | Upgrade to Pro+ | |
Thermo Fisher Scientific | NYSE | Healthcare | Healthcare Equipment & Supplies | US$154.50B | 24x | 2.49 | US$409.26 | 1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 40.9% Upside | Upgrade to Pro+ | |
Boston Scientific | NYSE | Healthcare | Healthcare Equipment & Supplies | US$148.31B | 72.8x | 5.03 | US$100.19 | -1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 11.2% Upside | Upgrade to Pro+ | |
Stryker | NYSE | Healthcare | Healthcare Equipment & Supplies | US$146.17B | 51.1x | -3.3 | US$382.41 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.7% Upside | Upgrade to Pro+ | |
Danaher | NYSE | Healthcare | Healthcare Equipment & Supplies | US$142.83B | 38.5x | -2.87 | US$199.54 | 1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 27.7% Upside | Upgrade to Pro+ | |
Essilor International SA | OTC Markets | Healthcare | Healthcare Equipment & Supplies | US$131.49B | 48x | 48.13 | US$142.97 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 7.6% Upside | Upgrade to Pro+ | |
Medtronic | NYSE | Healthcare | Healthcare Equipment & Supplies | US$112.55B | 24.1x | 0.74 | US$87.68 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 14.5% Upside | Upgrade to Pro+ | |
Siemens Healthineers ADR | OTC Markets | Healthcare | Healthcare Equipment & Supplies | US$59.48B | 26.4x | US$26.61 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Cencora Inc | NYSE | Healthcare | Healthcare Equipment & Supplies | US$55.11B | 32.9x | -5.58 | US$284.15 | -1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 11.9% Upside | Upgrade to Pro+ | |
Becton Dickinson | NYSE | Healthcare | Healthcare Equipment & Supplies | US$49.50B | 33.3x | 2.35 | US$172.63 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 12.4% Upside | Upgrade to Pro+ | |
Veeva Systems A | NYSE | Healthcare | Healthcare Equipment & Supplies | US$46.58B | 59.1x | 1.5 | US$284.63 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 1.9% Upside | Upgrade to Pro+ | |
Edwards Lifesciences | NYSE | Healthcare | Healthcare Equipment & Supplies | US$44.91B | 31.6x | 0.16 | US$76.55 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 2.3% Upside | Upgrade to Pro+ | |
Alcon | NYSE | Healthcare | Healthcare Equipment & Supplies | US$43.48B | 38.9x | 5.72 | US$87.67 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 24.5% Upside | Upgrade to Pro+ | |
IDEXX Labs | NASDAQ | Healthcare | Healthcare Equipment & Supplies | US$41.85B | 47.8x | 9.62 | US$519.77 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -0.2% Downside | Upgrade to Pro+ | |
Hoya Corp | OTC Markets | Healthcare | Healthcare Equipment & Supplies | US$39.65B | 28.8x | 2.27 | US$116.42 | 1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 29% Upside | Upgrade to Pro+ | |
Resmed ADR | OTC Markets | Healthcare | Healthcare Equipment & Supplies | US$36.87B | 28.1x | 0.74 | US$30 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ResMed | NYSE | Healthcare | Healthcare Equipment & Supplies | US$36.83B | 28.1x | 0.74 | US$251.53 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 11.9% Upside | Upgrade to Pro+ | |
DexCom | NASDAQ | Healthcare | Healthcare Equipment & Supplies | US$33.68B | 63.2x | -4.72 | US$85.76 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 16.6% Upside | Upgrade to Pro+ | |
Agilent Technologies | NYSE | Healthcare | Healthcare Equipment & Supplies | US$33.26B | 28.8x | -7.28 | US$117.04 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 20.6% Upside | Upgrade to Pro+ | |
GE HealthCare | NASDAQ | Healthcare | Healthcare Equipment & Supplies | US$32.79B | 14.1x | 0.38 | US$71.98 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 21.2% Upside | Upgrade to Pro+ | |
Terumo ADR | OTC Markets | Healthcare | Healthcare Equipment & Supplies | US$26.68B | 33x | 3.2 | US$18.03 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
STERIS | NYSE | Healthcare | Healthcare Equipment & Supplies | US$23.92B | 39.2x | 0.63 | US$243.13 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 8.1% Upside | Upgrade to Pro+ | |
Koninklijke Philips ADR | NYSE | Healthcare | Healthcare Equipment & Supplies | US$22.71B | 79.6x | 0.54 | US$23.50 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 43.2% Upside | Upgrade to Pro+ | |
Coloplast A | OTC Markets | Healthcare | Healthcare Equipment & Supplies | US$21.69B | 31.3x | -3.17 | US$9.58 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 24.9% Upside | Upgrade to Pro+ | |
Insulet | NASDAQ | Healthcare | Healthcare Equipment & Supplies | US$21.59B | 53.4x | 0.84 | US$306.51 | -1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 1.8% Upside | Upgrade to Pro+ | |
Waters | NYSE | Healthcare | Healthcare Equipment & Supplies | US$20.79B | 31.8x | 3.84 | US$349.29 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 7.2% Upside | Upgrade to Pro+ | |
Straumann ADR | OTC Markets | Healthcare | Healthcare Equipment & Supplies | US$20.73B | 37.1x | 0.64 | US$13.02 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 23.9% Upside | Upgrade to Pro+ | |
Sonova Holding AG | OTC Markets | Healthcare | Healthcare Equipment & Supplies | US$18.61B | 28.2x | -2.83 | US$62.51 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 19.7% Upside | Upgrade to Pro+ | |
Zimmer Biomet | NYSE | Healthcare | Healthcare Equipment & Supplies | US$18.43B | 20.5x | -8.56 | US$93.05 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 12.8% Upside | Upgrade to Pro+ | |
West Pharmaceutical Services | NYSE | Healthcare | Healthcare Equipment & Supplies | US$16.03B | 34.7x | -2.03 | US$222.85 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 32.8% Upside | Upgrade to Pro+ | |
Baxter | NYSE | Healthcare | Healthcare Equipment & Supplies | US$15.89B | -57.4x | 0.47 | US$30.94 | 2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 16.4% Upside | Upgrade to Pro+ | |
Olympus Corp | OTC Markets | Healthcare | Healthcare Equipment & Supplies | US$14.96B | 18.7x | -0.37 | US$13.27 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hologic | NASDAQ | Healthcare | Healthcare Equipment & Supplies | US$14.40B | 26.8x | 0.98 | US$64.58 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 12.6% Upside | Upgrade to Pro+ | |
Cooper | NASDAQ | Healthcare | Healthcare Equipment & Supplies | US$14.40B | 34.6x | 1.51 | US$72.11 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 39.1% Upside | Upgrade to Pro+ | |
Illumina | NASDAQ | Healthcare | Healthcare Equipment & Supplies | US$13.46B | -13.8x | -0.53 | US$84.54 | 2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 21.6% Upside | Upgrade to Pro+ | |
Smith&Nephew SNATS | NYSE | Healthcare | Healthcare Equipment & Supplies | US$13.15B | 31.9x | 0.55 | US$29.92 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 14% Upside | Upgrade to Pro+ | |
Align | NASDAQ | Healthcare | Healthcare Equipment & Supplies | US$13.07B | 32.7x | -3.44 | US$180.26 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 35.4% Upside | Upgrade to Pro+ | |
Solventum | NYSE | Healthcare | Healthcare Equipment & Supplies | US$12.95B | 32.3x | -0.47 | US$75.04 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 12.9% Upside | Upgrade to Pro+ | |
Fisher Paykel Healthcare | OTC Markets | Healthcare | Healthcare Equipment & Supplies | US$12.87B | 57.2x | 0.31 | US$20.70 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CochLear ADR | OTC Markets | Healthcare | Healthcare Equipment & Supplies | US$11.43B | 47.6x | 7.91 | US$86 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Revvity | NYSE | Healthcare | Healthcare Equipment & Supplies | US$10.96B | 38.3x | 0.38 | US$93 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 32.7% Upside | Upgrade to Pro+ | |
Sysmex Corp | OTC Markets | Healthcare | Healthcare Equipment & Supplies | US$10.19B | 27.6x | 3.27 | US$16.39 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Penumbra Inc | NYSE | Healthcare | Healthcare Equipment & Supplies | US$9.95B | 235.1x | -4.48 | US$256.65 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 21.7% Upside | Upgrade to Pro+ | |
Masimo | NASDAQ | Healthcare | Healthcare Equipment & Supplies | US$9.31B | -31.4x | 0.04 | US$171.70 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 12.3% Upside | Upgrade to Pro+ | |
Avantor | NYSE | Healthcare | Healthcare Equipment & Supplies | US$9.18B | 12.9x | 0.07 | US$13.47 | 3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 23.9% Upside | Upgrade to Pro+ | |
Demant ADR | OTC Markets | Healthcare | Healthcare Equipment & Supplies | US$8.87B | 20.6x | 0.52 | US$20.71 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Henry Schein | NASDAQ | Healthcare | Healthcare Equipment & Supplies | US$8.65B | 22x | 2.58 | US$71.04 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 10.7% Upside | Upgrade to Pro+ | |
Globus Medical | NYSE | Healthcare | Healthcare Equipment & Supplies | US$8.17B | 44.5x | 0.3 | US$60.24 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 33.5% Upside | Upgrade to Pro+ | |
ConvaTec ADR | OTC Markets | Healthcare | Healthcare Equipment & Supplies | US$8.13B | 44.1x | 0.88 | US$16.24 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -12.9% Downside | Upgrade to Pro+ |